Dr. Priya Rastogi
Overview
Priya Rastogi, MD, is currently Associate Professor of Medicine at the University of Pittsburgh School of Medicine. Dr. Rastogi received a Bachelor of Arts degree in Chemistry from Miami University at Oxford, Ohio. She earned her MD at Wright State University School of Medicine in Dayton, Ohio and completed her residency in Internal Medicine at Saint Joseph's Hospital in Denver, Colorado, where she received the Resident of the Year Award. Her Fellowship was completed at the University of Pittsburgh School of Medicine in Pittsburgh, PA. During her fellowship, Dr. Rastogi's research was focused on Herceptin-induced cardiotoxicity, and she was awarded a grant from the National Surgical Breast and Bowel Project. Dr. Rastogi is board certified in Internal Medicine and Medical Oncology by the American Board of Internal Medicine. She is an associate member of the American Society of Clinical Oncology and the American Association for Cancer Research. She has several abstracts and research articles in leading journals, including Seminars in Breast Disease, Oncology, and Diseases of the Breast. Dr. Rastogi practices in the Womens Cancer Center at Magee-Womens Hospital will see over 125 new breast cancer consultations and over 1250 patient visits in 2004. Dr. Rastogi has participated in the Introduction to Being a Physician course for first year medical students at the University of Pittsburgh School of Medicine for two years and is also active within the community for lectures and presentations.
Dr. Rastogi is rated as an Advanced provider by MediFind in the treatment of Angiosarcoma. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Angiosarcoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
300 Halket Street, Suite 4628, Pittsburgh, PA 15213
UPMC Hillman Cancer Center
Adam M. Brufsky, MD, PhD, FACP, is professor of medicine at the University of Pittsburgh School of Medicine and also serves as the associate division chief for the Division of Hematology/Oncology at the University of Pittsburgh School of Medicine's Department of Medicine. Dr. Brufsky is the medical director of the Magee-Women's Cancer Program, part of the UPMC Hillman Cancer Center, and UPMC Hillman Cancer Center; associate director for clinical investigations at UPMC Hillman Cancer Center; and codirector of the Comprehensive Breast Cancer Center. Dr. Brufsky is board-certified in internal medicine and medical oncology. He earned a medical and doctor of philosophy degrees from the University of Connecticut School of Medicine in Farmington, Conn.; completed a residency at Brigham and Women's Hospital, Harvard Medical School, and a fellowship at Dana-Farber Cancer Institute. Dr. Brufsky is a member of professional organizations, such as American Medical Association, Massachusetts Medical Society, American College of Physicians, American Society of Clinical Oncology, American Association for Cancer Research, Allegheny County Medical Society, Pennsylvania Medical Society, and Pennsylvania Oncologic Society. An active researcher, Dr. Brufsky has numerous abstracts and research articles in leading journals, and is principal investigator on a number of research grants funded by the National Institutes of Health, Susan G. Komen Foundation, and US Army - Breast Cancer Research Program. Dr. Brufsky is rated as an Elite provider by MediFind in the treatment of Angiosarcoma. His top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Gastrostomy.
UPMC Hillman Cancer Center
Melissa Burgess, MD, is an assistant professor at the University of Pittsburgh School of Medicine and a medical oncologist. She specializes in the treatment of soft tissue and bone sarcomas and Merkel cell carcinoma. Dr. Burgess is rated as an Elite provider by MediFind in the treatment of Angiosarcoma. Her top areas of expertise are Adult Soft Tissue Sarcoma, Merkel Cell Carcinoma, Liposarcoma, Chondrosarcoma, and Gamma Knife Radiosurgery.
West Virginia University Medical Corporation
Sobha Kurian is a Hematologist Oncology specialist and a Hematologist in Morgantown, West Virginia. Dr. Kurian is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. Her top areas of expertise are Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, and Paget Disease of the Breast. Dr. Kurian is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- AngiosarcomaDr. Rastogi isAdvanced. Learn about Angiosarcoma.
- Breast CancerDr. Rastogi isAdvanced. Learn about Breast Cancer.
- Inflammatory Breast CancerDr. Rastogi isAdvanced. Learn about Inflammatory Breast Cancer.
- Paget Disease of the BreastDr. Rastogi isAdvanced. Learn about Paget Disease of the Breast.